108 related articles for article (PubMed ID: 6358621)
1. [Can diabetic nephropathy be prevented?].
Viberti GC; Wiseman M; Mackintosch D; Keen H
Journ Annu Diabetol Hotel Dieu; 1983; ():79-88. PubMed ID: 6358621
[No Abstract] [Full Text] [Related]
2. The development of nephropathy in insulin-dependent diabetes mellitus is associated with poor glycemic control.
Feldt-Rasmussen B
Transplant Proc; 1994 Apr; 26(2):371-2. PubMed ID: 8171466
[No Abstract] [Full Text] [Related]
3. Renal function changes in diabetes.
Mogensen CE
Diabetes; 1976; 25(2 SUPPL):872-9. PubMed ID: 971791
[TBL] [Abstract][Full Text] [Related]
4. [Diabetic nephropathy].
Berden JH; Hoitsma AJ; Wetzels JF; Koene RA
Ned Tijdschr Geneeskd; 1985 Nov; 129(47):2247-50. PubMed ID: 4088328
[No Abstract] [Full Text] [Related]
5. Treatment of diabetic nephropathy: a rational approach based on its pathophysiology.
Tuttle KR; DeFronzo RA; Stein JH
Semin Nephrol; 1991 Mar; 11(2):220-35. PubMed ID: 1674623
[No Abstract] [Full Text] [Related]
6. The point of no-return for the diabetic kidney is beyond clinical proteinuria.
Selam JL; Giraud P; Mirouze J
Diabet Med; 1984 Sep; 1(3):242. PubMed ID: 6242808
[No Abstract] [Full Text] [Related]
7. Progression of diabetic nephropathy in type 1 diabetic patients.
Najafian B; Mauer M
Diabetes Res Clin Pract; 2009 Jan; 83(1):1-8. PubMed ID: 19070384
[TBL] [Abstract][Full Text] [Related]
8. [Prediction, screening and treatment of renal complications of diabetes].
Marre M; Larger E
Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
[TBL] [Abstract][Full Text] [Related]
9. Comments on a pilot study to test the effect of pulsatile insulin infusion on type 1 diabetes mellitus patients with proteinuria.
Leinung MC
Metabolism; 2010 May; 59(5):763-4; author reply 764-5. PubMed ID: 20206368
[No Abstract] [Full Text] [Related]
10. [Diabetic nephropathy].
Körner A
Orv Hetil; 1985 Jul; 126(28):1701-5. PubMed ID: 3936000
[No Abstract] [Full Text] [Related]
11. Diabetic nephropathy--what does it cause to develop?
de Jong PE
Neth J Med; 1988 Oct; 33(3-4):101-5. PubMed ID: 3067096
[No Abstract] [Full Text] [Related]
12. [The kidney as a target organ in diabetic patients with arterial hypertension].
Viberti G
Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
[TBL] [Abstract][Full Text] [Related]
13. Controversies on the prevention of diabetic nephropathy.
Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of diabetic nephropathy.
Wittmann I; Molnár GA; Degrell P; Wagner Z; Tamaskó M; Laczy B; Brasnyó P; Wagner L; Nagy J
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S36-42. PubMed ID: 15955373
[TBL] [Abstract][Full Text] [Related]
15. Prevention of diabetic nephropathy: markers of disease and perspectives for intervention.
Viberti GC; Wiseman MJ; Bending JJ
Diabet Med; 1986 May; 3(3):208-11. PubMed ID: 2951170
[No Abstract] [Full Text] [Related]
16. [Predicting diabetic nephropathy].
Mogensen CE; Christensen CK
Journ Annu Diabetol Hotel Dieu; 1984; ():333-49. PubMed ID: 6399537
[No Abstract] [Full Text] [Related]
17. The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy.
Viberti G; Keen H
Diabetes; 1984 Jul; 33(7):686-92. PubMed ID: 6376224
[No Abstract] [Full Text] [Related]
18. [Ischemic nephropathy in patients with diabetes mellitus].
Shamkhalova MSh; Klefortova II; Zaĭtseva NV; Shestakova MV
Ter Arkh; 2007; 79(4):76-80. PubMed ID: 17564025
[No Abstract] [Full Text] [Related]
19. The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes.
Ruggenenti P; Remuzzi G
Exp Nephrol; 1996; 4 Suppl 1():53-60. PubMed ID: 9001898
[TBL] [Abstract][Full Text] [Related]
20. [Can diabetic nephropathy be prevented? Or what is the point of no return?].
Grimaldi A; Baumelou A
Ann Med Interne (Paris); 1987; 138(7):483-5. PubMed ID: 3326450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
